Depression and Anxiety Trial, Recruiting NCT06534684 Sponsor: University Hospital of North Norway Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06534684
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with depression that is at least moderate in severity
  • People whose current depressive episode has lasted more than 2 weeks but less than 2 years
  • People whose medication has remained unchanged for at least 3 weeks before the first treatment session
  • People who are willing to give informed consent, are able to follow the treatment schedule, and pass the safety checks required for the brain stimulation (iTBS) and brain scan (MRI) procedures

Who may not be able to join:

  • People whose current depression is only mild in severity
  • People whose depression is severe enough to require a hospital stay or electroconvulsive therapy (ECT)
  • People whose current depressive episode appears to be clearly caused by grief or a recent major stressful life event
  • People with a diagnosis of bipolar disorder
  • People with a diagnosis of borderline personality disorder
  • People currently experiencing psychotic symptoms (such as hallucinations or delusions)
  • People who have had problems with alcohol or drug misuse or addiction in the last 6 months
  • People with a current eating disorder
  • People with obsessive-compulsive disorder (OCD)
  • People with post-traumatic stress disorder (PTSD)
  • People who have ever had a seizure at any point in their life
  • People with any neurological or brain-related conditions, or who have had brain surgery
  • People with heart conditions or other serious physical health conditions
  • People who have metal implants or devices in their body, such as a pacemaker or prosthetic eye equipment
  • People with a diagnosis of autism
  • People who are pregnant
  • People currently taking antipsychotic medications, benzodiazepines, or any other medication known to affect brain excitability (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 77649234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital of North Norway
Registry
ClinicalTrials.gov
Start date
12 February 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Data from magnetic resonance imaging - white matter integrity; Data from magnetic resonance imaging - cortical thickness; Data from magnetic resonance imaging - cerebral activity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov